CANCELLED: Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
More information coming soon Learning Objectives Target Audience Faculty Registration Details
12 events found.
Onsite Course
Events
-
-
Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria
-
AD-LEARN Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders?
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThe course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular, cerebral SPET and PET will be addressed. Learning […]
-
AD-LEARN mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThe course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles, radiolabelling […]
-
-
GMP for Radiopharmaceuticals
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThe GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality, from batch to batch, for clinical use. […]
-
-
Focus on FDG PET/CT in Inflammatory and Infectious Diseases
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaInflammation comes from the Latin word inflammare, to ignite or to set on fire – we want to ignite your interest in imaging inflammation and infection. Inflammatory and infectious diseases […]
-
-
Nuclear Medicine in Breast Cancer Based on FOCUS Meeting 6
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaBreast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in […]
-
-
Dose-Effect Response to Targeted Radionuclide Therapy
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThis intensive 1,5-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response […]
€950 -
-
Nuclear Medicine in FUO/IUO: Why Are Children Different?
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThis 1,5-day course focuses on the growing field of integrated imaging in infectious and inflammatory diseases in children, with an emphasis on hybrid imaging. The panelists will introduce the participants […]
-
-
Bringing Therapy Radioisotopes into Clinical Radiopharmacy – Some Regulatory Aspects
Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria"Bringing Therapy Radioisotopes into Clinical Radiopharmacy" is an advanced course designed to bridge the gap between isotope production, radiopharmaceutical preparation and clinical application. This course focuses on the practical and regulatory […]
-
-
PET in Multiple Myeloma: Evidences, Applications and Perspectives
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThis onsite course on FDG PET/CT in multiple myeloma is a focused, practice-oriented training programme designed to enhance expertise in metabolic imaging of plasma cell disorders. The course integrates concise […]
-
-
Prostate Cancer Theranostics
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaRadiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e., staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment […]
-
-
Biomarker Assessment for an Early Biological Diagnosis of Alzheimer’s Disease
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaLearning Objectives · Understand the concordance and complementary roles of tau-PET, quantitative amyloid PET measures, and CSF Aβ42/40 in Alzheimer’s disease diagnostics. · Recognize clinically relevant quantitative thresholds for Aβ […]